Soleno Therapeutics, Inc. (SLNO)
May 18, 2026 - SLNO was delisted (reason: acquired by NBIX)
53.01
0.00 (0.00%)
Inactive · Last trade price on May 15, 2026

Soleno Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
133.0370.1187.93169.6814.621.3
Short-Term Investments
122.57235.37203.51---
Cash & Short-Term Investments
255.6305.47291.44169.6814.621.3
Cash Growth
-11.85%4.82%71.76%1062.04%-31.46%-56.72%
Accounts Receivable
47.1428.21----
Receivables
47.1428.21----
Inventory
17.3115.02----
Prepaid Expenses
6.337.112.451.681.051.12
Total Current Assets
326.38355.81293.89171.3615.6522.42
Property, Plant & Equipment
4.092.382.980.420.160.45
Long-Term Investments
273.38200.6227.21---
Other Intangible Assets
4.374.866.818.7510.6912.64
Other Long-Term Assets
0.160.160.080.17-0.04
Total Assets
608.39563.83330.97180.6926.535.55

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
12.3912.448.883.151.783.25
Accrued Expenses
27.6827.829.346.534.94.15
Current Portion of Leases
1.160.730.530.270.160.28
Other Current Liabilities
14.0520.38-1.560.480.32
Total Current Liabilities
58.0561.3618.7511.517.318.01
Long-Term Debt
49.8749.8649.83---
Long-Term Leases
3.241.962.470.13-0.18
Other Long-Term Liabilities
1.430.5314.8111.558.849.58
Total Liabilities
112.59113.7285.8623.1816.1517.76

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.050.050.050.030.010.08
Additional Paid-In Capital
897.58881.02696.97433.89247.76231.07
Retained Earnings
-399.99-431.37-452.26-276.41-237.42-213.36
Comprehensive Income & Other
-1.840.420.36---
Total Common Equity
495.8450.12245.11157.5110.3517.79
Shareholders' Equity
495.8450.12245.11157.5110.3517.79
Total Liabilities & Equity
608.39563.83330.97180.6926.535.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
54.2852.5552.830.40.160.46
Net Cash (Debt)
474.7453.54265.82169.2814.4520.85
Net Cash Growth
100.16%70.62%57.03%1071.72%-30.70%-57.52%
Net Cash Per Share
8.778.666.6210.261.723.92
Filing Date Shares Outstanding
52.1251.6245.8632.468.175.34
Total Common Shares Outstanding
51.7252.2945.731.688.165.32
Working Capital
268.33294.45275.14159.858.3314.42
Book Value Per Share
9.598.615.364.971.273.34
Tangible Book Value
491.43445.25238.31148.76-0.355.16
Tangible Book Value Per Share
9.508.525.214.70-0.040.97
Machinery
-0.220.20.10.10.1
Leasehold Improvements
-0.090.05---
SEC Filings: 10-K · 10-Q